SCHEMBL2070135

SCHEMBL2070135

Cc1nc(-c2ccc(Cl)cc2)sc1COCC1CNCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.41
PPARD Q03181 1/20 0.41
RAB9A P51151 2/20 0.38
HTR2A P28223 2/20 0.38
SLC6A4 P31645 2/20 0.38
ADRB2 P07550 1/20 0.38
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR2B P41595 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ADRA2C P18825 1/20 0.38
MAPT P10636 6/20 0.37
LMNA P02545 4/20 0.37
PPARA Q07869 1/20 0.37
SGK1 O00141 2/20 0.36
ALOX5 P09917 1/20 0.36
THRB P10828 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070577 0.80 CHRNB2 (0.43) FFAR1PPARDRAB9APPARAALOX5
SCHEMBL2069085 0.74 PPARA (0.42) FFAR1PPARDRAB9AMAPTPPARA
SCHEMBL2069857 0.74 PPARA (0.52) FFAR1PPARDRAB9AMAPTLMNA
SCHEMBL2069858 0.74 PPARA (0.52) FFAR1PPARDRAB9AMAPTLMNA
SCHEMBL2069690 0.73 MAPT (0.46) FFAR1RAB9AMAPTLMNAPPARA
SCHEMBL2068822 0.73 PPARA (0.58) PPARDRAB9AMAPTPPARAKDM4E
SCHEMBL2071325 0.71 PPARA (0.46) FFAR1PPARDRAB9AMAPTLMNA
SCHEMBL2070132 0.70 SLC6A4 (0.44) RAB9ASLC6A4SLC6A2SLC6A3KDM4E
Fumaric Acid SCHEMBL10844175 0.69 HRH1 (0.41) HTR2ASLC6A4ADRB2HTR1ASLC6A2
Maleic Acid SCHEMBL10844166 0.69 HRH1 (0.41) HTR2ASLC6A4ADRB2HTR1ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative PPARA, PPARG, PPARD FFAR1 7/4885PPARD 3/4885RAB9A 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.